Method and system to control and enhance prescribing and dispensing of medication

• US 8,719,055 B2
• Filed: 11/05/2009
• Issued: 05/06/2014
• Est. Priority Date: 11/05/2008
• Status: Expired due to Fees

• Current Assignee: Rx Controls LLC
• Original Assignee: Rx Controls LLC
• Inventors: Huser, Frederic J., Gold, Steven B.
• Primary Examiner(s): Fuelling, Michael
• Application Number:
  US12/613,262
• Publication Number:
  US 20100256984A1
• Time in Patent Office: 1,643 Days
• Field of Search: 705 2- 3
• US Class Current: 705/3
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 15/00 ICT specially adapted for medical reports, e.g. generation or transmission thereof
• CPC Class Codes: G16H 20/13 delivered from dispensers
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage
• CPC Class Codes: G16H 70/60 relating to pathologies

Abstract

Computer implemented methods and systems for controlling the dispensation of a prescription drug to a patient with a medical condition. The methods and systems may restrict the prescription and dispensation of prescription drugs at the physician and pharmacy level. Determination of whether a patient should receive a subsequent prescription of a drug is based on the effectiveness of the drug and the adverse side effects associated with the drug. This can be used by state and federal regulators, physicians and pharmacists to control, evaluate and monitor the use of drugs on an individual patient basis. Furthermore, the methods and systems provide a national registry in which drug effectiveness data in individual patients is collected which can be aggregated to provide information on population-based drug efficacy.

Claims

1. A method for controlling a refilling of a drug to a patient to prevent off-label use of the subject drug comprising the steps of:

(a) receiving a prescription for the drug for the patient,

(b) entering information on the patient and the drug into a patient registry database, wherein the drug information comprises information sufficient to identify the drug and its labeler, strength and dosage form,

(c) dispensing the drug in an N-of-1 test kit to the patient according to the prescription,

(d) accessing an analysis report stored in the patient registry database, wherein;

the analysis report is generated by a computer programmed to analyze data from the N-of-1 drug test kit stored in the patient registry database, the analysis report indicating whether the patient is receiving an intended labeled benefit from the drug specified by a manufacturer of the drug and by a government agency,

(e) receiving a prescription for a refill of the drug, and

(f) preventing off-label use of the drug by permitting dispensation of the refill to a patient who, based on the analysis report, is receiving the intended labeled benefit from the drug and restricting dispensation of the refill to a patient who, based on the analysis report, is not receiving the intended labeled benefit from the drug, wherein there are at least two patients, and at least one of the patients is engaging in off-label use, and not receiving the intended labeled benefit from the drug, and at least one of the patients is receiving the intended labeled benefit from the drug, and wherein the test kit and drug are associated by at least one identifying code number.

2. The method of claim 1, wherein the data from the N-of-1 test kit comprises patient drug response information and side effect information.

3. The method of claim 1, wherein said analysis report is accessed electronically.

4. The method of claim 1, wherein the appropriateness of the drug is further determined by evaluating the N-of-1 test kit data for serious side effects.

5. The method of claim 1 wherein, the method is repeated if a higher or lower dose of the drug is prescribed.

6. The method of claim 1, wherein dispensation of the drug is blocked if the N-of-1 test kit data are not submitted within a predetermined time.

7. The method of claim 6, wherein the predetermined time is one month after completion of the N-of-1 prescription course.

8. The method of claim 1, wherein the patient registry database is stored on a non-transitory computer readable medium and is accessible by dispensing pharmacies.

9. The method of claim 1, wherein the drug is associated with serious side effects.